CD155 Antibody PerCP-eFluor 710 46-1550-42 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

CD155 Antibody PerCP-eFluor 710

Staining of U937 cells with Mouse IgG1 K Isotype Control PerCP-eFluor® 710 (Product # 46-4714) (blue histogram) or Anti-Human CD155 PerCP-eFluor® 710 (purple histogram). Total viable cells, as determined by Fixable Viability Dye eFluor® 660 (Product # 65-0864), were used for analysis.
Flow

Staining of U937 cells with Mouse IgG1 K Isotype Control PerCP-eFluor® 710 (Product # 46-4714) (blue histogram) or Anti-Human CD155 PerCP-eFluor® 710 (purple histogram). Total viable cells, as determined by Fixable Viability Dye eFluor® 660 (Product # 65-0864), were used for analysis.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
CD155 Antibody PerCP-eFluor 710

Thermo Fisher Scientific's CD155 Antibody PerCP-eFluor 710 is a Mouse monoclonal antibody. The CD155 Antibody PerCP-eFluor 710 was generated using PVR, and PVR cell adhesion molecule as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD155 Antibody PerCP-eFluor 710
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number46-1550-42
Antibody TypePrimary
Storage4°C, store in dark, DO NOT FREEZE!
Storage Temperature4° C, store in dark, DO NOT FREEZE!
PurityAffinity chromatography
ReactivityHuman (Hu)
ClonalityMonoclonal
NCBI Gene AliasesCD155, HVED, NECL5, Necl-5, PVS, TAGE4
NCBI Full Gene NamePVR cell adhesion molecule
ApplicationsFlow Cytometry (FCM)
HostMouse
Clone2H7CD155
IsotypeIgG1 kappa
TargetCD155
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
Conjugate/TagPerCP-eFluor™ 710
Concentration5 µL/Test
Quantity100 Tests

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) PD-1 Blockade Reinvigorates Bone Marrow CD8⁺ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ InhibitorsClinical cancer research : an official journal of the American Association for Cancer ResearchApril 1, 2020Kwon M, Kim CG, Lee H, Cho H, Kim Y, Lee EC, Choi SJ, Park J, Seo IH, Bogen B, et al.

(2) TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemiaOncoimmunologyJanuary 1, 2017Catakovic K, Gassner FJ, Ratswohl C, Zaborsky N, Rebhandl S, Schubert M, Steiner M, Gutjahr JC, Pleyer L, Egle A, et al.

Be the First to Write a Review!